Company / Operating Income per Share
Foghorn Therapeutics Inc. Operating Income per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.85
FY2025
5-year range
-$2.80 / -$1.85
FY2021-FY2025
Trend
+27.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $-2.80 to $-1.85 over the past 2 years.
Based on SEC 10-K filings.
-1.85 in FY2025.
Improved from $-2.80 to $-1.85 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share increased 27.6% year-over-year.
- Lowest operating income per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.20 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.85 | +27.6% |
| FY2024 | -$2.55 | +8.9% |
| FY2023 | -$2.80 | -14.9% |
| FY2022 | -$2.44 | -30.9% |
| FY2021 | -$1.86 | +82.2% |
| FY2020 | -$10.49 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026